Navigation Links
Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
Date:3/21/2011

BLUE BELL, Pa., March 21, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a U.S. Department of Defense Small Business Innovation Research Grant to test the feasibility of delivering DNA vaccines by intradermal electroporation simultaneously to two or more spatially distinct sites on the body. The purpose of such a prototype device would be to mitigate potential immune interference that may result from combination vaccines that are formulated together. The device design would also facilitate rapid vaccination against multiple emerging infectious disease or pandemic threats and better meet the demands of quickly vaccinating U.S. troops stationed around the world.

Dr. J. Joseph Kim, Inovio's president & CEO, said, "This device would provide a means to painlessly deliver multiple vaccines simultaneously, bringing improved protection against infectious diseases to both military and civilian populations. This collaboration builds on Inovio's strong relationship with the U.S. Department of Defense, in which Inovio is bringing medical innovation to multiple bio-defense projects."

The research effort will seek to determine optimal spatial separation between vaccination sites on the body in order to avoid immune interference between multiple vaccines. The new specialized device resulting from this research will leverage Inovio's latest intradermal DNA vaccine delivery technology. These devices are all based on the company's proprietary electroporation delivery platform, which uses millisecond electrical pulses to dramatically improve cellular uptake of the vaccine and resulting immune responses. Final testing will involve delivery of Lassa and Hantaan virus vaccines simultaneously at spatially distinct sites. Las
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
4. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
5. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
8. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
9. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
10. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
11. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
(Date:9/1/2015)... September 1, 2015 Diabetes, ... 2015 market research report that charts the changing ... the added health concerns resulting from the metabolic ... factors: cardiovascular disease (CVD). Complete report ... spread across 270 pages, profiling 66 companies and ...
(Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 2Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 3Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Md., April 26, 2012 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... providing health care services in China through the operations ... care hospitals and affiliated ambulatory clinics, today announced that ... first quarter of 2012 ended March 31, 2012 on ...
... 2012 Medical sales recruitment specialists Advance ... new global medical device survey for 2012-2013 suggesting a ... climate. The report, which was published this ... a highly detailed analysis drawn from ICD research,s panel ...
Cached Medicine Technology:Chindex International, Inc. to Report First Quarter 2012 Financial Results 2Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry 2
(Date:9/1/2015)... ... 2015 , ... The premier online medical education company for ... in podiatric, surgical and wound care conferences . The Residency Education Summits ... at the podium and across the table during hands-on surgical and advanced wound ...
(Date:8/31/2015)... ... August 31, 2015 , ... Jvion, ... their latest predictive use case focused on helping hospital perform under the Center ... program, hospital payments are adjusted based on performance across four domains related to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Southern Vacation Rentals – a ... up with fellow South Walton property management company, 360 Blue, in support ... remote parts of the world. The two companies will collect any unopened food items ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Lisle family law ... William Scott has been nominated by his peers to earn a “Leading Lawyers” distinction. ... percent of attorneys in the state of Illinois. The nomination process is based on ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... Patients ... from and those who are interested in learning more about the procedure beyond the ... Mohebi. , Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand ...
Breaking Medicine News(10 mins):Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2
... Institute for Child Health Research shows an association between ... research findings have just been published online in the ... of Nutrition studies at the Institute, Associate Professor Wendy ... 1800 adolescents from the long-term Raine Study and classified ...
... efforts may be much more sensitive than previously realized to ... scientists at Harvard University report this week. In some cases, ... the difference between a minor, localized outbreak and an epidemic ... Proceedings of the Royal Society B , comes amidst one ...
... HealthDay Reporter , WEDNESDAY, July 28 (HealthDay News) ... see someone having what appears to be a heart attack, ... can be as effective as CPR that includes mouth-to-mouth breathing, ... July 29 issue of the New England Journal of ...
... (TZDS), including rosiglitazone and pioglitazone, may be at increased ... for publication in The Endocrine Society,s Journal of ... taking both loop diuretics and TZDs may also be ... shows that increased fracture risk is associated with higher ...
... Reporter , WEDNESDAY, July 28 (HealthDay News) -- A ... of men with metastatic tumors resistant to standard hormonal ... Provenge (sipuleucel-T), improved survival by about four months compared ... However, with a round of treatment potentially costing $93,000, ...
... Serena Gordon HealthDay Reporter , WEDNESDAY, July 28 ... one day eliminate the need for the multiple daily finger ... their blood sugar levels. The new device was tested ... monitored their blood sugar without the need for daily recalibration. ...
Cached Medicine News:Health News:Western diet link to ADHD 2Health News:Small increases in vaccine cost can cause large gaps in protection 2Health News:Chest Compressions Alone Best With CPR 2Health News:Chest Compressions Alone Best With CPR 3Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 3Health News:Implantable Sensor Measures Blood Sugar Levels 2Health News:Implantable Sensor Measures Blood Sugar Levels 3
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... to prevent a microplate from sticking to the block ... level of sealing performance, which means you can use ...
... Designed for use with the Moto Alpha unit, these ... cycle sequencing, in which several successive runs may be ... Alpha unit is engineered to prevent a microplate from ... pads provide an improved level of sealing performance, which ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: